Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Wages, Salaries and Other
Ratios

Sagimet Biosciences (SGMT) Shares Issued (2023 - 2024)

Sagimet Biosciences has reported Shares Issued over the past 2 years, most recently at $14000.0 for Q3 2024.

  • Quarterly results put Shares Issued at $14000.0 for Q3 2024, up 133.33% from a year ago — trailing twelve months through Dec 2024 was $114000.0 (up 1800.0% YoY), and the annual figure for FY2024 was $114000.0, up 1800.0%.
  • Shares Issued for Q3 2024 was $14000.0 at Sagimet Biosciences, up from -$105.6 million in the prior quarter.
  • Over the last five years, Shares Issued for SGMT hit a ceiling of $105.8 million in Q1 2024 and a floor of -$105.6 million in Q2 2024.